Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.4827 USD 4.93% Market Closed
Updated: May 17, 2024

Redhill Biopharma Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redhill Biopharma Ltd
Income from Continuing Operations Peer Comparison

Comparables:
TEVA
TARO
I
INCR
MDWD
R
REKA

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Redhill Biopharma Ltd
NASDAQ:RDHL
Income from Continuing Operations
$23.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Income from Continuing Operations
-$617m
CAGR 3-Years
47%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Income from Continuing Operations
$45.6m
CAGR 3-Years
N/A
CAGR 5-Years
-32%
CAGR 10-Years
-18%
I
InterCure Ltd
TASE:INCR
Income from Continuing Operations
₪17.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Mediwound Ltd
NASDAQ:MDWD
Income from Continuing Operations
-$6.7m
CAGR 3-Years
10%
CAGR 5-Years
-3%
CAGR 10-Years
2%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Income from Continuing Operations
-₪8.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Redhill Biopharma Ltd's Income from Continuing Operations?
Income from Continuing Operations
23.9m USD

Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Income from Continuing Operations amounts to 23.9m USD.